Privia Health [PRVA] vs Veeva Systems [VEEV] Detailed Stock Comparison
Privia Health
NASDAQ
Loading...
Veeva Systems
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Privia Health wins in 5 metrics, Veeva Systems wins in 14 metrics, with 0 ties. Veeva Systems appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Privia Health | Veeva Systems | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 192.00 | 59.15 | Veeva Systems |
| Price-to-Book Ratio | 3.79 | 7.33 | Privia Health |
| Debt-to-Equity Ratio | 0.91 | 1.24 | Privia Health |
| PEG Ratio | 81.23 | 1.48 | Veeva Systems |
| EV/EBITDA | 79.67 | 48.88 | Veeva Systems |
| Profit Margin (TTM) | 0.78% | 27.34% | Veeva Systems |
| Operating Margin (TTM) | 0.64% | 30.79% | Veeva Systems |
| EBITDA Margin (TTM) | 0.64% | 30.79% | Veeva Systems |
| Return on Equity | 2.71% | 14.06% | Veeva Systems |
| Return on Assets (TTM) | 1.04% | 6.90% | Veeva Systems |
| Free Cash Flow (TTM) | $109.28M | $1.09B | Veeva Systems |
| 1-Year Return | 6.88% | 45.77% | Veeva Systems |
| Price-to-Sales Ratio (TTM) | 1.36 | 15.98 | Privia Health |
| Enterprise Value | $2.21B | $39.63B | Veeva Systems |
| EV/Revenue Ratio | 1.16 | 13.88 | Privia Health |
| Gross Profit Margin (TTM) | 9.64% | 77.10% | Veeva Systems |
| Revenue per Share (TTM) | $16 | $18 | Veeva Systems |
| Earnings per Share (Diluted) | $0.11 | $4.72 | Veeva Systems |
| Beta (Stock Volatility) | 0.81 | 0.96 | Privia Health |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Privia Health vs Veeva Systems Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Privia Health | 2.70% | 3.35% | 3.05% | -14.58% | -15.06% | 8.30% |
| Veeva Systems | 2.05% | -0.54% | 0.46% | 16.15% | 20.52% | 33.26% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Privia Health | 6.88% | -41.71% | -41.44% | -41.44% | -41.44% | -41.44% |
| Veeva Systems | 45.77% | 28.01% | 5.12% | 1,057.15% | 532.15% | 532.15% |
Performance & Financial Health Analysis: Privia Health vs Veeva Systems
| Metric | PRVA | VEEV |
|---|---|---|
| Market Information | ||
| Market Cap | $2.59B | $45.62B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 1,278,308 | 1,023,150 |
| 90 Day Avg. Volume | 976,666 | 1,195,860 |
| Last Close | $21.27 | $280.61 |
| 52 Week Range | $16.47 - $26.09 | $190.38 - $296.72 |
| % from 52W High | -18.47% | -5.43% |
| All-Time High | $50.77 (Jun 28, 2021) | $343.96 (Aug 02, 2021) |
| % from All-Time High | -58.11% | -18.42% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.23% | 0.17% |
| Quarterly Earnings Growth | -0.23% | 0.41% |
| Financial Health | ||
| Profit Margin (TTM) | 0.01% | 0.27% |
| Operating Margin (TTM) | 0.01% | 0.31% |
| Return on Equity (TTM) | 0.03% | 0.14% |
| Debt to Equity (MRQ) | 0.91 | 1.24 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $5.57 | $38.11 |
| Cash per Share (MRQ) | $3.18 | $37.14 |
| Operating Cash Flow (TTM) | $91.86M | $1.20B |
| Levered Free Cash Flow (TTM) | $92.29M | $1.05B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | $0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Privia Health vs Veeva Systems
| Metric | PRVA | VEEV |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 192.00 | 59.15 |
| Forward P/E | 81.23 | 41.30 |
| PEG Ratio | 81.23 | 1.48 |
| Price to Sales (TTM) | 1.36 | 15.98 |
| Price to Book (MRQ) | 3.79 | 7.33 |
| Market Capitalization | ||
| Market Capitalization | $2.59B | $45.62B |
| Enterprise Value | $2.21B | $39.63B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.16 | 13.88 |
| Enterprise to EBITDA | 79.67 | 48.88 |
| Risk & Other Metrics | ||
| Beta | 0.81 | 0.96 |
| Book Value per Share (MRQ) | $5.57 | $38.11 |
Financial Statements Comparison: Privia Health vs Veeva Systems
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | PRVA | VEEV |
|---|---|---|
| Revenue/Sales | $480.10M | $759.04M |
| Cost of Goods Sold | $434.34M | $173.82M |
| Gross Profit | $45.76M | $585.22M |
| Research & Development | N/A | $184.03M |
| Operating Income (EBIT) | $5.22M | $233.73M |
| EBITDA | $7.12M | $243.55M |
| Pre-Tax Income | $8.15M | $298.82M |
| Income Tax | $2.10M | $70.63M |
| Net Income (Profit) | $6.05M | $228.19M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | PRVA | VEEV |
|---|---|---|
| Cash & Equivalents | $469.33M | $1.96B |
| Total Current Assets | $886.47M | $6.71B |
| Total Current Liabilities | $470.81M | $1.46B |
| Long-Term Debt | $3.05M | $66.57M |
| Total Shareholders Equity | $709.53M | $6.21B |
| Retained Earnings | $-175.01M | $3.68B |
| Property, Plant & Equipment | $1.01M | $122.23M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | PRVA | VEEV |
|---|---|---|
| Operating Cash Flow | $-9.30M | $810.54M |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | $-24.06M | $877.16M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | PRVA | VEEV |
|---|---|---|
| Shares Short | 3.25M | 4.62M |
| Short Ratio | 3.70 | 3.58 |
| Short % of Float | 0.05% | 0.03% |
| Average Daily Volume (10 Day) | 1,278,308 | 1,023,150 |
| Average Daily Volume (90 Day) | 976,666 | 1,195,860 |
| Shares Outstanding | 120.31M | 162.58M |
| Float Shares | 104.96M | 149.92M |
| % Held by Insiders | 0.07% | 0.09% |
| % Held by Institutions | 1.00% | 0.88% |
Dividend Analysis & Yield Comparison: Privia Health vs Veeva Systems
| Metric | PRVA | VEEV |
|---|---|---|
| Last 12-Month Dividend | $0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | $0.05 | N/A |
| 3-Year Avg Dividend Yield | 0.18% | N/A |
| 3-Year Total Dividends | $0.15 | N/A |
| Ex-Dividend Date | Mar 28, 2023 | N/A |